Drug intelligence / Profile preview

Gluma Desensitizer

Development stage
Phase 3
Lead developer
Kulzer
Modality
Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Gluma Desensitizer is a topical dental desensitizing agent used to treat and prevent dentin hypersensitivity. It is primarily indicated for the reduction or elimination of pain in exposed cervical areas not requiring restoration, as well as for alleviating or preventing dentinal sensitivity after preparation of teeth to receive direct or indirect restorations[1][4][5][6]. The product contains glutaraldehyde and hydroxyethyl methacrylate (HEMA) as its main active ingredients. Its mechanism of action involves the precipitation of plasma proteins within the dentinal tubules, which reduces dentinal permeability and occludes peripheral tubules, thereby inhibiting fluid movement that causes sensitivity[5][9]. Additionally, it provides a seal that acts as a microbial barrier. Gluma Desensitizer is applied topically to exposed dentin surfaces without mixing or curing and has been widely studied in clinical settings since its launch in 1992[4][6].

Brand names
Gluma Desensitizer
Other names
GLUMAglutaraldehyde/2-hydroxyethylmethacrylateHEMA-glutaraldehyde desensitizer

Beyond the preview

Go deeper on Gluma Desensitizer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gluma Desensitizer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call